Effect of drugs on renal development

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 1, 2011, Pages 212-217

  Schreuder, Michiel F ^a   Bueters, Ruud R ^a   Huigen, Marleen C ^a   Russel, Frans G M ^a   Masereeuw, Rosalinde ^a   Van Den Heuvel, Lambertus P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; FUROSEMIDE; GENTAMICIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTAGLANDIN SYNTHASE INHIBITOR;

BLADDER MALFORMATION; CHILDHOOD DISEASE; DRUG EFFECT; ECTOPIC KIDNEY; GESTATIONAL AGE; HUMAN; HYDRONEPHROSIS; INFANT DISEASE; KIDNEY AGENESIS; KIDNEY DEVELOPMENT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY MALFORMATION; KIDNEY TUBULE DAMAGE; MULTICYSTIC DYSPLASTIC KIDNEY; NEPHRON; NEPHROTOXICITY; PREGNANT WOMAN; PREMATURITY; RENAL REPLACEMENT THERAPY; SHORT SURVEY;

ANIMALS; FEMALE; HUMANS; KIDNEY; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM; URINARY TRACT;

EID: 79251494151     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04740510     Document Type: Short Survey

References (51)

1. Perazella MA: Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol 4: 1275-1283, 2009
2. Quaggin SE, Kreidberg J: Embryology of the kidney. In: Brenner and Rector's the Kidney, 8th Ed., edited by Brenner BM, Philadelphia, Saunders, Elsevier, 2008, pp 3-24
3. Nyengaard JR, Bendtsen TF: Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 232: 194-201, 1992
4. Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE: Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int 69: 671-678, 2006
5. Schreuder M, Delemarre-van de Waal H, van Wijk A: Consequences of intrauterine growth restriction for the kidney. Kidney Blood Press Res 29: 108-125, 2006
6. Rodriguez MM, Gomez AH, Abitbol CL, Chandar JJ, Duara S, Zilleruelo GE: Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 7: 17-25, 2004
7. Rodriguez MM, Gomez A, Abitbol C, Chandar J, Montane B, Zilleruelo G: Comparative renal histomorphometry: A case study of oligonephropathy of prematurity. Pediatr Nephrol 20: 945-949, 2005
8. De Curtis M, Rigo J: Extrauterine growth restriction in very-low-birthweight infants. Acta Paediatr 93: 1563-1568, 2004
9. Schreuder MF, Nyengaard JR, Remmers F, van Wijk JA, Delemarre-van de Waal HA: Postnatal food restriction in the rat as a model for a low nephron endowment. Am J Physiol Renal Physiol 291: F1104-F1107, 2006
10. The Netherlands Perinatal Registry: Perinatal care in the Netherlands 2005. Utrecht, The Netherlands Perinatal Registry, 2008
11. Eichenwald EC, Stark AR: Management and outcomes of very low birth weight. N Engl J Med 358: 1700-1711, 2008
12. Kerecuk L, Schreuder MF, Woolf AS: Renal tract malformations: Perspectives for nephrologists. Nat Clin Pract Nephrol 4: 312-325, 2008
13. Keller G, Zimmer G, Mall G, Ritz E, Amann K: Nephron number in patients with primary hypertension. N Engl J Med 348: 101-108, 2003
14. Lacoste M, Cai Y, Guicharnaud L, Mounier F, Dumez Y, Bouvier R, Dijoud F, Gonzales M, Chatten J, Delezoide AL, Daniel L, Joubert M, Laurent N, Aziza J, Sellami T, Amar HB, Jarnet C, Frances AM, Daikha-Dahmane F, Coulomb A, Neuhaus TJ, Foliguet B, Chenal P, Marcorelles P, Gasc JM, Corvol P, Gubler MC: Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: Role of the renin-angiotensin system. J Am Soc Nephrol 17: 2253-2263, 2006
15. Lewis MA, Shaw J, Sinha M, Adalat S, Hussain F, Inward C: UK Renal Registry 11th Annual Report (December 2008): Chapter 13 Demography of the UK paediatric renal replacement therapy population. Nephron Clin Pract 111[Suppl 1]: c257-c267, 2009
16. Mallie JP, Coulon G, Billerey C, Faucourt A, Morin JP: In utero aminoglycosides-induced nephrotoxicity in rat neonates. Kidney Int 33: 36-44, 1988
17. Gilbert T, Lelievre-Pegorier M, Merlet-Benichou C: Long-term effects of mild oligonephronia induced in utero by gentamicin in the rat. Pediatr Res 30: 450-456, 1991
18. Gilbert T, Nabarra B, Merlet-Benichou C: Light- and electron-microscopic analysis of the kidney in newborn rats exposed to gentamicin in utero. Am J Pathol 130: 33-43, 1988
19. Gilbert T, Lelievre-Pegorier M, Malienou R, Meulemans A, Merlet-Benichou C: Effects of prenatal and postnatal exposure to gentamicin on renal differentiation in the rat. Toxicology 43: 301-313, 1987
20. Gilbert T, Gaonach S, Moreau E, Merlet-Benichou C: Defect of nephrogenesis induced by gentamicin in rat metanephric organ culture. Lab Invest 70: 656-666, 1994
21. Kent AL, Maxwell LE, Koina ME, Falk MC, Willenborg D, Dahlstrom JE: Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatr Res 62: 307-312, 2007
22. Tendron A, Decramer S, Justrabo E, Gouyon JB, Semama DS, Gilbert T: Cyclosporin A administration during pregnancy induces a permanent nephron deficit in young rabbits. J Am Soc Nephrol 14: 3188-3196, 2003
23. Tendron-Franzin A, Gouyon JB, Guignard JP, Decramer S, Justrabo E, Gilbert T, Semama DS: Long-term effects of in utero exposure to cyclosporin A on renal function in the rabbit. J Am Soc Nephrol 15: 2687-2693, 2004
24. Chang CP, McDill BW, Neilson JR, Joist HE, Epstein JA, Crabtree GR, Chen F: Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery. J Clin Invest 113: 1051-1058, 2004
25. Ohlsson A, Walia R, Shah S: Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev CD003481, 2008
26. Komhoff M, Wang JL, Cheng HF, Langenbach R, McKanna JA, Harris RC, Breyer MD: Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 57: 414-422, 2000
27. Kent AL, Douglas-Denton R, Shadbolt B, Dahlstrom JE, Maxwell LE, Koina ME, Falk MC, Willenborg D, Bertram JF: Indomethacin, ibuprofen and gentamicin administered during late stages of glomerulogenesis do not reduce glomerular number at 14 days of age in the neonatal rat. Pediatr Nephrol 24: 1143-1149, 2009
28. Vieira-Filho LD, Lucena-Junior JM, Barreto IS, Angelim JL, Paixao AD: Repercussion of acetylsalicylic acid during fetal development on later renal hemodynamics of rats. Fundam Clin Pharmacol 22: 379-386, 2008
29. Yosipiv IV, el Dahr SS: Activation of angiotensin-generating systems in the developing rat kidney. Hypertension 27: 281-286, 1996
30. Guron G, Friberg P: An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18: 123-137, 2000
31. Sekine T, Miura K, Takahashi K, Igarashi T: Children's toxicology from bench to bed - Drug-induced renal injury (1): The toxic effects of ARB/ACEI on fetal kidney development. J Toxicol Sci 34[Suppl 2]: SP245-SP250, 2009
32. Guron G, Marcussen N, Nilsson A, Sundelin B, Friberg P: Postnatal time frame for renal vulnerability to enalapril in rats. J Am Soc Nephrol 10: 1550-1560, 1999
33. Woods LL, Rasch R: Perinatal ANG II programs adult blood pressure, glomerular number, and renal function in rats. Am J Physiol 275: R1593-R1599, 1998
34. Roberts D, Dalziel S: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3: CD004454, 2006
35. de Vries WB, van den BP, Goldschmeding R, de Weger RA, Bal MP, van Bel F, van Oosterhout MF: Neonatal dexamethasone treatment in the rat leads to kidney damage in adulthood. Pediatr Res 67: 72-76, 2010
36. + exchanger by dexamethasone. Am J Physiol Regul Integr Comp Physiol 292: R1230-R1235, 2007
37. Dagan A, Kwon HM, Dwarakanath V, Baum M: Effect of renal denervation on prenatal programming of hypertension and renal tubular transporter abundance. Am J Physiol Renal Physiol 295: F29-F34, 2008
38. Bramlage CP, Schlumbohm C, Pryce CR, Mirza S, Schnell C, Amann K, Amstrong VW, Eitner F, Zapf A, Feldon J, Oellerich M, Fuchs E, Muller GA, Strutz F: Prenatal dexamethasone exposure does not alter blood pressure and nephron number in the young adult marmoset monkey. Hypertension 54: 1115-1122, 2009
39. Schell-Feith EA, Kist-van Holthe JE, Conneman N, van Zwieten PH, Holscher HC, Zonderland HM, Brand R, van der Heijden BJ: Etiology of nephrocalcinosis in preterm neonates: Association of nutritional intake and urinary parameters. Kidney Int 58: 2102-2110, 2000
40. Mallie JP, Boudzoumou P: Functional renal maturation in rat neonates after prenatal exposure to furosemide. Pediatr Nephrol 10: 458-460, 1996
41. Mallie JP, Gerard A, Gerard H: Does the in utero exposure to furosemide delay the renal maturation? Pediatr Pharmacol (New York) 5: 131-138, 1985
42. Cai Q, Dmitrieva NI, Ferraris JD, Brooks HL, van Balkom BW, Burg M: Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance. Proc Natl Acad Sci U S A 102: 503-508, 2005
43. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Hirtz D, Le Guen C: Practice parameter update: Management issues for women with epilepsy - Focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73: 133-141, 2009
44. Carta M, Cimador M, Giuffre M, Sergio M, Di Pace MR, De GE, Corsello G: Unilateral multicystic dysplastic kidney in infants exposed to antiepileptic drugs during pregnancy. Pediatr Nephrol 22: 1054-1057, 2007
45. Tendron A, Gouyon JB, Decramer S: In utero exposure to immunosuppressive drugs: Experimental and clinical studies. Pediatr Nephrol 17: 121-130, 2002
46. Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA: Reviewing the evidence for mycophenolate mofetil as a new teratogen: Case report and review of the literature. Am J Med Genet A 149A: 1241-1248, 2009
47. Sabuda-Widemann D, Grabensee B, Schwandt C, Blume C: Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells. Nephrol Dial Transplant 24: 52-61, 2009
48. Dawrant MJ, Giles S, Bannigan J, Puri P: Adriamycin produces a reproducible teratogenic model of vertebral, anal, cardiovascular, tracheal, esophageal, renal, and limb anomalies in the mouse. J Pediatr Surg 42: 1652-1658, 2007
49. Park D, Kim S, Kang H, Oh J, Jang JY, Shin S, Kim TK, Choi YJ, Lee SH, Kim KY, Joo SS, Kim YB: Preventive effect of piperonyl butoxide on cyclophosphamide-induced teratogenesis in rats. Birth Defects Res B Dev Reprod Toxicol 86: 402-408, 2009
50. Andiman WA, Chernoff MC, Mitchell C, Purswani M, Oleske J, Williams PL, Spiegel H, Gona P, Seage GR III: Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: Associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors. Pediatr Infect Dis J 28: 619-625, 2009
51. Luyckx VA, Brenner BM: The clinical importance of nephron mass. J Am Soc Nephrol 21: 898-910, 2010